Egetis Therapeutics

Major Shareholding Notification • Nov 4, 2019

Issuer Egetis Therapeutics AB (publ)

Holder

Fjärde AP-fonden

Instrument

Instrument	Aktier
Before the transaction
Shares	3,200,000
Voting rights	3,200,000
Transaction
Reason for major shareholding notification Other
Date	31/10/2019
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	3,200,000
Directly held voting rights	3,200,000
Indirectly held voting rights	0
Percentage
Directly held shares	5.98 %
Directly held voting rights	5.98 %
Indirectly held voting rights	0 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	5.98 %	3,200,000
Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total	5.98 %	3,200,000
Group total holdings
Voting rights	3,200,000
Percentage of voting rights 5.98
	Notes (other relevant informations according to law)
Flaggning görs eftersom bolaget noteras på huvudlistan.
Published
04/11/2019 11:43

Contact Name Jannis Kitsakis Phone 070-6038023 Email jannis.kitsakis@ap4.se

CLOSE PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25